According to a press release from the company, Neuspera Medical announced FDA approval of its Neuspera ultraminiaturized neurostimulation system.
Neuspera uses a wireless device and wearable platform to provide peripheral stimulation for patients suffering from chronic pain.
“We look forward to bringing this innovative technology to physicians and patients in the U.S.,” Steffen Hovard, CEO of Neuspera Medical, said in the release. “The Neuspera ultra-miniaturized system has the potential to revolutionize the way physicians treat patients
